Results show that E2F1 enhanced Nanog expression at the transcriptional level, providing a potential mechanism by which LINC0051/miR-185-3p/E2F1 axis promotes breast cancer stemness and tumorigenesis (Fig. 6). This evidence concerns the gene NANOG and breast cancer.